Pre-earnings options volume in Gevo (GEVO) is 1.3x normal with calls leading puts 4:1. Implied volatility suggests the market is anticipating a ...

ENGLEWOOD, Colo., March 07, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leading developer ...

Gevo, Inc. (NASDAQ: GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals ...

The delay in the earnings release is required to allow additional time to ... The Company will issue a separate press release when a rescheduled date and time has been determined. Gevo is a ...

Revenue for the quarter exceeded forecasts by approximately $4.11 million. The company's stock price surged by 8.49% in premarket trading. Recorlev and Gevo products drove significant revenue growth.

Gevo (GEVO), Inc. announced that it will delay the issuance of its fourth quarter and full year 2024 earnings release and investor conference call previously scheduled for March 6, 2025.